Independent Director · Neumora Therapeutics, Inc. (NMRA)

Chair, Nominating/Governance Committee

Alaa Halawa director compensation at Neumora Therapeutics: $106K

Fiscal year 2025 director compensation for Alaa Halawa at Neumora Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 17, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Alaa Halawa’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Alaa Halawa and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Neumora Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Neumora Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$62,500$0$43,632$0$106,132
FY2024$62,500$199,995$218,260—$480,755
FY2023$51,189—$620,007—$671,196

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Neumora Therapeutics, Inc. DEF 14A filed April 17, 2026, accession 0001193125-26-161489, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Neumora Therapeutics, Inc. filed document, accession 0001193125-26-161489. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2026.

Get the Neumora Therapeutics Board Governance Report

$106,132 Alaa Halawa, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 17, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Neumora Therapeutics pays directors a $45,000 cash retainer and $400,000 in equity.

Committees

FY2025 · as the proxy prints them

Compensation · Nominating/Governance (Chair)

The rest of the Neumora Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
David PiacquadIndependent Director$97,382
Kristina BurowIndependent Director$111,132
Matthew FustIndependent Director$134,257
Maykin Ho, Ph.DIndependent Director$103,632
Paul L. BernsChair of the Board—

The full Neumora Therapeutics compensation record

free company brief

This page is one director within Neumora Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order NMRA

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report